Arkolith/Insider Trading/APTO/Form 4

Vincent Mark D.

InsiderAptose Biosciences Inc. (APTO) · full profile →Form 4 · filed Jul 1, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2026Disposed to issuer(D)14$1.72$240

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2026Disposed to issuer(D)3K—$00
Jun 30, 2026Disposed to issuer(D)100K—$00
Jun 30, 2026Disposed to issuer(D)50K—$00
Jun 30, 2026Disposed to issuer(D)50K—$00
Jun 30, 2026Disposed to issuer(D)154K—$00
Jun 30, 2026Disposed to issuer(D)40K—$00
Jun 30, 2026Disposed to issuer(D)10K—$00
Jun 30, 2026Disposed to issuer(D)5K—$00
Jun 30, 2026Disposed to issuer(D)60K—$00
Jun 30, 2026Disposed to issuer(D)50K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-26-000898) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML